Literature DB >> 31612260

[The 2019 FIGO classification for cervical carcinoma-what's new?]

L-C Horn1, C E Brambs2, S Opitz3, U A Ulrich4, A K Höhn3.   

Abstract

Numerous therapeutic and prognostic studies of cervical carcinoma have necessitated a revision of the FIGO classification.For microinvasive carcinomas, the horizontal dimension is no longer considered and diagnosis and staging will solely be made by the depth of cervical stromal invasion. Lymphovascular invasion beyond the deepest point of stromal infiltration by tumor cells does not alter the stage.There will be a new subclassification of macroinvasive carcinoma confined to the uterine cervix, which will be made by largest tumor extension as follows: FIGO IB1/T1b1 - invasive carcinoma >0.5 cm depth of stromal invasion and ≤2 cm in largest dimension, FIGO IBII/T1b2: - invasive carcinoma >2 cm and ≤4 cm, FIGO IBII/T1b3 - invasive carcinoma >4 cm. Pelvic as well as para-aortic lymph nodes will be defined as regional nodes. Pelvic lymph node metastases only will be categorised as FIGO IIIC1/pN1a and para-aortic lymph node involvement with or without concomitant pelvic involvement will be FIGO IIIC2/pN1b. Uterine corpus as well as adnexal involvement are not relevant for staging purpose.

Entities:  

Keywords:  Cervix and carcinoma; FIGO-classification; Prognosis; Staging; TNM-classification; Tumor size

Mesh:

Year:  2019        PMID: 31612260     DOI: 10.1007/s00292-019-00675-w

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  42 in total

1.  A cut-off value of 2 cm in tumor size is of prognostic value in surgically treated FIGO stage IB cervical cancer.

Authors:  Lars-Christian Horn; Karl Bilek; Uta Fischer; Jens Einenkel; Bettina Hentschel
Journal:  Gynecol Oncol       Date:  2014-04-24       Impact factor: 5.482

2.  Factors associated with parametrial involvement in stage IB1 cervical cancer and identification of patients suitable for less radical surgery.

Authors:  Junichi Kodama; Tomoyuki Kusumoto; Keiichiro Nakamura; Noriko Seki; Atsushi Hongo; Yuji Hiramatsu
Journal:  Gynecol Oncol       Date:  2011-06-24       Impact factor: 5.482

3.  Stratified mucin-producing intraepithelial lesion (SMILE): report of a case series with associated pathological findings.

Authors:  David P Boyle; W Glenn McCluggage
Journal:  Histopathology       Date:  2015-01-15       Impact factor: 5.087

Review 4.  Redefining early cervical neoplasia: recent progress.

Authors:  Marisa R Nucci; Christopher P Crum
Journal:  Adv Anat Pathol       Date:  2007-01       Impact factor: 3.875

5.  Ovarian metastases in early-stage cervical cancer (IA2-IIA): a multicenter retrospective study of 1965 patients (a Cooperative Task Force study).

Authors:  F Landoni; V Zanagnolo; L Lovato-Diaz; A Maneo; R Rossi; A Gadducci; S Cosio; T Maggino; E Sartori; C Tisi; P Zola; F Marocco; E Botteri; K Ravanelli
Journal:  Int J Gynecol Cancer       Date:  2007-02-16       Impact factor: 3.437

Review 6.  Control of cancer of the cervix in low- and middle-income countries.

Authors:  Lynette Denny
Journal:  Ann Surg Oncol       Date:  2015-01-21       Impact factor: 5.344

Review 7.  [Current TNM/FIGO classification for cervical and endometrial cancer as well as malignant mixed müllerian tumors. Facts and background].

Authors:  L-C Horn; K Schierle; D Schmidt; U Ulrich; A Liebmann; C Wittekind
Journal:  Pathologe       Date:  2011-05       Impact factor: 1.011

Review 8.  Oncological outcomes after fertility-sparing surgery for cervical cancer: a systematic review.

Authors:  Enrica Bentivegna; Sebastien Gouy; Amandine Maulard; Cyrus Chargari; Alexandra Leary; Philippe Morice
Journal:  Lancet Oncol       Date:  2016-06       Impact factor: 41.316

9.  Isolated para-aortic lymph node metastasis in FIGO stage IA2-IB2 carcinoma of the cervix: Revisiting the role of surgical assessment.

Authors:  Marcela G Del Carmen; Rene Pareja; Alexander Melamed; Juliana Rodriguez; Anna Greer; Rachel M Clark; Laurel W Rice
Journal:  Gynecol Oncol       Date:  2018-07-17       Impact factor: 5.482

10.  Surgical resection based on ontogenetic cancer field theory for cervical cancer: mature results from a single-centre, prospective, observational, cohort study.

Authors:  Michael Höckel; Benjamin Wolf; Katja Schmidt; Meinhard Mende; Bahriye Aktas; Rainer Kimmig; Nadja Dornhöfer; Lars-Christian Horn
Journal:  Lancet Oncol       Date:  2019-08-02       Impact factor: 41.316

View more
  3 in total

Review 1.  [Current WHO classification of the female genitals : Many new things, but also some old].

Authors:  Doris Mayr; Elisa Schmoeckel; Anne Kathrin Höhn; Grit Gesine Ruth Hiller; Lars-Christian Horn
Journal:  Pathologe       Date:  2021-04-06       Impact factor: 1.011

Review 2.  [Revised German guidelines on the diagnosis and treatment of carcinoma of the uterine cervix-what's new for pathologists in 2021?]

Authors:  Lars-Christian Horn; Matthias W Beckmann; Markus Follmann; Martin C Koch; Monika Nothacker; Birgit Pöschel; Frederik Stübs; Dietmar Schmidt; Anne Kathrin Höhn
Journal:  Pathologie (Heidelb)       Date:  2022-02-21

3.  Diagnosis of Early Cervical Cancer with a Multimodal Magnetic Resonance Image under the Artificial Intelligence Algorithm.

Authors:  Zhenge Zhang; Chongyuan Zhang; Li Xiao; Shuirong Zhang
Journal:  Contrast Media Mol Imaging       Date:  2022-03-23       Impact factor: 3.161

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.